{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:55:31Z","timestamp":1790776531810,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81902082"],"award-info":[{"award-number":["81902082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Open Foundation of Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University","award":["2021TTM007"],"award-info":[{"award-number":["2021TTM007"]}]},{"name":"the National Key Research and Development Program of China","award":["2021YFC2300800\uff0c2021YFC2300802"],"award-info":[{"award-number":["2021YFC2300800\uff0c2021YFC2300802"]}]},{"name":"the Natural Science Foundation of Guangdong Province","award":["2018A0303130025"],"award-info":[{"award-number":["2018A0303130025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In China, people infected with hepatitis B virus (HBV) are commonly found in areas with a high prevalence of <jats:italic>Clonorchis sinensis<\/jats:italic>, a trematode worm. Published studies have reported that the progression of hepatitis B is affected by coinfection <jats:italic>C. sinensis<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Clinical data from a total of 72 patients with <jats:italic>C. sinensis<\/jats:italic> and\u00a0HBV (as sole infection or with coinfections) and 29 healthy individuals were analysed. We also incubated the hepatic stellate cell line LX-2 with total proteins from <jats:italic>C. sinensis<\/jats:italic> adult worms (<jats:italic>Cs<\/jats:italic>TPs) and HBV-positive sera. In addition, the human hepatoblastoma cell line HepG2.2.15 was treated with the antiviral drug entecavir (ETV), <jats:italic>Cs<\/jats:italic>TPs and the anti-<jats:italic>C. sinensis<\/jats:italic> drug praziquantel (PZQ).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our clinical data indicated that the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin\u00a0(TB) and hyaluronic acid\u00a0(HA) were significantly higher in patients with coinfection than in those infected with HBV only. In cell models, compared with the model in which LX-2 cells were incubated with HBV-positive sera (HBV group), transcripts of alpha-smooth muscle actin and types I and III collagen were significantly elevated in the models of LX-2 cells treated with <jats:italic>Cs<\/jats:italic>TPs and HBV-positive sera (<jats:italic>Cs<\/jats:italic>TP+HBV group), while the messenger RNA levels of tumour necrosis factor-\u03b1, interleukin (IL)-1\u03b2 and IL-6 in the <jats:italic>Cs<\/jats:italic>TP+HBV group were clearly lower. The HBV surface antigen and hepatitis B e-antigen levels were higher in the HepG2.2.15 cells treated with ETV and <jats:italic>Cs<\/jats:italic>TPs than in those in the ETV group and in the cells administered a mixture of ETV, <jats:italic>Cs<\/jats:italic>TPs and PZQ.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results confirmed that <jats:italic>C. sinensis<\/jats:italic> and HBV coinfection could aggravate the progression of liver fibrosis. <jats:italic>Cs<\/jats:italic>TPs might promote chronic inflammation of the liver in individuals with HBV infection, resulting in the development of hepatic fibrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphic abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-022-05548-5","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T14:08:04Z","timestamp":1670854084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models"],"prefix":"10.1186","volume":"15","author":[{"given":"Huimin","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengchang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"5548_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0140-6736(15)60313-0","volume":"387","author":"M-B Qian","year":"2016","unstructured":"Qian M-B, Utzinger J, Keiser J, Zhou X-N. Clonorchiasis. Lancet. 2016;387:800\u201310.","journal-title":"Lancet"},{"key":"5548_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2019.105246","volume":"202","author":"ZH Deng","year":"2020","unstructured":"Deng ZH, Fang YY, Zhang QM, Mao Q, Pei FQ, Liu MR. The control of clonorchiasis in Guangdong province, southern China. Acta Trop. 2020;202:105246.","journal-title":"Acta Trop"},{"key":"5548_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2019.105309","volume":"203","author":"BK Na","year":"2020","unstructured":"Na BK, Pak JH, Hong SJ. Clonorchis sinensis and clonorchiasis. Acta Trop. 2020;203:105309.","journal-title":"Acta Trop"},{"key":"5548_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.apar.2018.03.006","volume":"100","author":"D Wang","year":"2018","unstructured":"Wang D, Young ND, Korhonen PK, Gasser RB. Clonorchis sinensis and clonorchiasis: the relevance of exploring genetic variation. Adv Parasitol. 2018;100:155\u2013208.","journal-title":"Adv Parasitol"},{"key":"5548_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","volume":"20","author":"NP Nelson","year":"2016","unstructured":"Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis. 2016;20:607\u201328.","journal-title":"Clin Liver Dis"},{"key":"5548_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12879-019-4428-y","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Men P, Xiao Y, Gao P, Lv M, Yuan Q, et al. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis. 2019;19:811.","journal-title":"BMC Infect Dis"},{"key":"5548_CR7","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1007\/s00436-017-5572-1","volume":"116","author":"Y Shi","year":"2017","unstructured":"Shi Y, Jiang Z, Yang Y, Zheng P, Wei H, Lin Y, et al. Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma. Parasitol Res. 2017;116:2645\u20139.","journal-title":"Parasitol Res"},{"key":"5548_CR8","doi-asserted-by":"publisher","first-page":"11749","DOI":"10.1038\/s41598-020-68684-x","volume":"10","author":"Y Gao","year":"2020","unstructured":"Gao Y, Li Y, Liu X, Zhang T, Yu G, Wang Y, et al. High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China. Sci Rep-Uk. 2020;10:11749.","journal-title":"Sci Rep-Uk"},{"key":"5548_CR9","unstructured":"Xie F. Clinical significance of Clonorchis sinensis antibodies dectection in HBV. Chinese J Parasitic Dis Control. 2005;2:95\u20138 (in Chinese)."},{"key":"5548_CR10","first-page":"94","volume":"32","author":"H Mou","year":"2009","unstructured":"Mou H, Wang L, Wang J, Jin B, Jin H. Discussion on clonorchiasis and HBV. Heilongjiang Med J Pharm. 2009;32:94.","journal-title":"Heilongjiang Med J Pharm"},{"key":"5548_CR11","doi-asserted-by":"publisher","unstructured":"Meng Z, Chen Y, Lu M. Advances in targeting the innate and adaptive immune systems to cure chronic hepatitis B virus infection. Front Immunol. 2020;10:3127. https:\/\/doi.org\/10.3389\/fimmu.2019.03127.","DOI":"10.3389\/fimmu.2019.03127"},{"key":"5548_CR12","doi-asserted-by":"publisher","unstructured":"Koda S, Zhu X, Zheng K, Yan C. Molecular mechanisms of Clonorchis sinensis-host interactions and implications for vaccine development. Front Cell Dev Biol. 2022;9:781768. https:\/\/doi.org\/10.3389\/fcell.2021.781768.","DOI":"10.3389\/fcell.2021.781768"},{"key":"5548_CR13","first-page":"1538","volume":"23","author":"D Kong","year":"2020","unstructured":"Kong D, Li X, Zhang B, Yan C, Tang R, Zheng K. The characteristics of CD4(+)T-helper cell subset differentiation in experimental Clonorchis sinensis-infected FVB mice. Iran J Basic Med Sci. 2020;23:1538\u201343.","journal-title":"Iran J Basic Med Sci"},{"key":"5548_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004806","volume":"10","author":"W Li","year":"2016","unstructured":"Li W, Dong H, Huang Y, Chen T, Kong X, Sun H, et al. Clonorchis sinensis co-infection could affect the disease state and treatment response of HBV patients. Plos Neglect Trop D. 2016;10:e4806.","journal-title":"Plos Neglect Trop D"},{"key":"5548_CR15","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/gb-2011-12-10-r107","volume":"12","author":"X Wang","year":"2011","unstructured":"Wang X, Chen W, Huang Y, Sun J, Men J, Liu H, et al. The draft genome of the carcinogenic human liver fluke Clonorchis sinensis. Genome Biol. 2011;12:R107.","journal-title":"Genome Biol"},{"key":"5548_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006251","volume":"12","author":"L Zhao","year":"2018","unstructured":"Zhao L, Shi M, Zhou L, Sun H, Zhang X, He L, et al. Clonorchis sinensis adult-derived proteins elicit Th2 immune responses by regulating dendritic cells via mannose receptor. PLoS Negl Trop Dis. 2018;12:e6251.","journal-title":"PLoS Negl Trop Dis"},{"key":"5548_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3947\/ic.2013.45.1.32","volume":"45","author":"J Chai","year":"2013","unstructured":"Chai J. Praziquantel treatment in trematode and cestode infections: an update. Infect Chemother. 2013;45:32\u201343.","journal-title":"Infect Chemother"},{"key":"5548_CR18","unstructured":"Hines-Kay J. Transcriptional analysis of Schistosoma mansoni treated with sub-lethal doses of the anthelmintic drug praziquantel. MSc thesis. Albuquerque: University of New Mexico; 2011."},{"key":"5548_CR19","doi-asserted-by":"publisher","unstructured":"Xiao Y, Liu C, Tang W, Zhang H, Chen X. Evans blue inhibits HBV replication through a dual antiviral mechanism by targeting virus binding and capsid assembly. Front Microbiol. 2019;10:2638. https:\/\/doi.org\/10.3389\/fmicb.2019.02638.","DOI":"10.3389\/fmicb.2019.02638"},{"key":"5548_CR20","first-page":"223","volume":"45","author":"SJ Adnani Sadati","year":"2016","unstructured":"Adnani Sadati SJ, Farahnak A, Molaei Rad MB, Golestani A, Eshraghiyan MR. A comparison between the effects of albendazole and mebendazole on the enzymatic activity of excretory\/secretory products of Echinococcus granulosus protoscoleces in vitro. Iran J Public Health. 2016;45:223\u20139.","journal-title":"Iran J Public Health"},{"key":"5548_CR21","first-page":"3409","volume":"13","author":"Z Li","year":"2021","unstructured":"Li Z, Cao H, Yao M, Lei X. Effect of acupuncture combined with Shenqi Yigan Decoction on liver function and T cell subsets in patients with HBV-induced liver fibrosis. Am J Transl Res. 2021;13:3409\u201317.","journal-title":"Am J Transl Res"},{"key":"5548_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/hep.32220","volume":"75","author":"P K\u00f6nigshofer","year":"2022","unstructured":"K\u00f6nigshofer P, Hofer BS, Brusilovskaya K, Simbrunner B, Petrenko O, W\u00f6ran K, et al. Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies. Hepatology. 2022;75:610\u201322.","journal-title":"Hepatology"},{"key":"5548_CR23","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.3748\/wjg.v21.i24.7427","volume":"21","author":"H Enomoto","year":"2015","unstructured":"Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroentero. 2015;21:7427\u201335.","journal-title":"World J Gastroentero"},{"key":"5548_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.hpb.2021.09.001","volume":"24","author":"T Matsumoto","year":"2022","unstructured":"Matsumoto T, Aoki T, Shimizu T, Park KH, Shiraki T, Sakuraoka Y, et al. Prognostic significance of preoperative hyaluronic acid level in patients with hepatocellular carcinoma. HPB (Oxford). 2022;24:525\u201334.","journal-title":"HPB (Oxford)"},{"key":"5548_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-2893.1998.00100.x","volume":"5","author":"VS Wong","year":"1998","unstructured":"Wong VS, Hughes V, Trull A, Wight DGD, Petrik J, Alexander GJM. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepatitis. 1998;5:187\u201392.","journal-title":"J Viral Hepatitis"},{"key":"5548_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10238-015-0388-8","volume":"16","author":"M Gudowska","year":"2016","unstructured":"Gudowska M, Gruszewska E, Panasiuk A, Cylwik B, Flisiak R, \u015awiderska M, et al. Hyaluronic acid concentration in liver diseases. Clin Exp Med. 2016;16:523\u20138.","journal-title":"Clin Exp Med"},{"key":"5548_CR27","first-page":"626","volume":"24","author":"A Tran","year":"2000","unstructured":"Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, et al. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol. 2000;24:626\u201330.","journal-title":"Gastroenterol Clin Biol"},{"key":"5548_CR28","first-page":"229","volume":"20","author":"H Jin","year":"2012","unstructured":"Jin H, Li Z. Correlation between serum hyaluronic acid and HBV DNA levels in patients with hepatitis B-associated cirrhosis. Shijie Huaren Xiaohua Zazhi. 2012;20:229\u201332.","journal-title":"Shijie Huaren Xiaohua Zazhi"},{"key":"5548_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13550-015-0151-x","volume":"5","author":"D Li","year":"2015","unstructured":"Li D, He L, Guo H, Chen H, Shan H. Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging. Ejnmmi Res. 2015;5:71.","journal-title":"Ejnmmi Res"},{"key":"5548_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev-cellbio-100617-062855","volume":"34","author":"MH Sherman","year":"2018","unstructured":"Sherman MH. Stellate cells in tissue repair, inflammation, and cancer. Annu Rev Cell Dev Biol. 2018;34:333\u201355.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"5548_CR31","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473\u201392.","journal-title":"Compr Physiol"},{"key":"5548_CR32","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1152\/ajpcell.00230.2013","volume":"305","author":"A Mallat","year":"2013","unstructured":"Mallat A, Lotersztajn S. Cellular mechanisms of tissue fibrosis 5 novel insights into liver fibrosis. Am J Physiol Cell Physiol. 2013;305:789\u201399.","journal-title":"Am J Physiol Cell Physiol."},{"key":"5548_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355.","journal-title":"Mol Aspects Med"},{"key":"5548_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125\u201372.","journal-title":"Physiol Rev"},{"key":"5548_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40139-015-0093-z","volume":"3","author":"YM Yang","year":"2015","unstructured":"Yang YM, Seki E. TNF\u03b1 in liver fibrosis. Curr Pathobiol Rep. 2015;3:253\u201361.","journal-title":"Curr Pathobiol Rep"},{"key":"5548_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153118","volume":"11","author":"S Robert","year":"2016","unstructured":"Robert S, Gicquel T, Bodin A, Lagente V, Boichot E. Characterization of the MMP\/TIMP imbalance and collagen production induced by IL-1\u03b2 or TNF-\u03b1 release from human hepatic stellate cells. PLoS ONE. 2016;11:e153118.","journal-title":"PLoS ONE"},{"key":"5548_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","volume":"54","author":"L Xu","year":"2005","unstructured":"Xu L, Hui AY, Albanis E, Arthur MJ, O\u2019Byrne SM, Blaner WS, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54:142\u201351.","journal-title":"Gut"},{"key":"5548_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13071-019-3561-1","volume":"12","author":"S Sun","year":"2019","unstructured":"Sun S, Li H, Yuan Y, Wang L, He W, Xie H, et al. Preventive and therapeutic effects of Trichinella spiralis adult extracts on allergic inflammation in an experimental asthma mouse model. Parasit Vectors. 2019;12:326.","journal-title":"Parasit Vectors"},{"key":"5548_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/cei.13251","volume":"196","author":"B Wangala","year":"2019","unstructured":"Wangala B, Gantin RG, Vo\u00dfberg PS, Vovor A, Poutouli WP, Komlan K, et al. Inflammatory and regulatory CCL and CXCL chemokine and cytokine cellular responses in patients with patent mansonella perstans filariasis. Clin Exp Immunol. 2019;196:111\u201322.","journal-title":"Clin Exp Immunol"},{"key":"5548_CR40","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1128\/IAI.01149-12","volume":"81","author":"EA McDonald","year":"2013","unstructured":"McDonald EA, Kurtis JD, Acosta L, Gundogan F, Sharma S, Pond-Tor S, et al. Schistosome egg antigens elicit a proinflammatory response by trophoblast cells of the human placenta. Infect Immun. 2013;81:704\u201312.","journal-title":"Infect Immun"},{"key":"5548_CR41","first-page":"59","volume":"8","author":"G Guo","year":"2009","unstructured":"Guo G, Tan D, Zhu P, Liu F. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2. Hepatobil Pancreat Dis Int. 2009;8:59\u201364.","journal-title":"Hepatobil Pancreat Dis Int"},{"key":"5548_CR42","first-page":"1455","volume":"122","author":"X Liu","year":"2009","unstructured":"Liu X, Zhu S, You H, Cong M, Liu T, Wang B, et al. Hepatitis B virus infects hepatic stellate cells and affects their proliferation and expression of collagen type I. Chinese Med J-Peking. 2009;122:1455\u201361.","journal-title":"Chinese Med J-Peking"},{"key":"5548_CR43","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00436-014-3972-z","volume":"113","author":"X Wang","year":"2014","unstructured":"Wang X, Hu F, Hu X, Chen W, Huang Y, Yu X. Proteomic identification of potential Clonorchis sinensis excretory\/secretory products capable of binding and activating human hepatic stellate cells. Parasitol Res. 2014;113:3063\u201371.","journal-title":"Parasitol Res"},{"key":"5548_CR44","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00436-020-06651-1","volume":"119","author":"M Shang","year":"2020","unstructured":"Shang M, Sun H, Wu Y, Gong Y, Tang Z, Meng F, et al. In vivo and in vitro studies using Clonorchis sinensis adult-derived total protein (CsTP) on cellular function and inflammatory effect in mouse and cell model. Parasitol Res. 2020;119:1641\u201352.","journal-title":"Parasitol Res"},{"key":"5548_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00421-008-0733-7","volume":"103","author":"D Jiang","year":"2008","unstructured":"Jiang D, Jiang Z, Han F, Zhang Y, Li Z. HGF suppresses the production of collagen type III and \u03b1-SMA induced by TGF-\u03b21 in healing fibroblasts. Eur J Appl Physiol. 2008;103:489\u201393.","journal-title":"Eur J Appl Physiol"},{"key":"5548_CR46","doi-asserted-by":"publisher","unstructured":"Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis. 2001;21:397-416. https:\/\/doi.org\/10.1055\/s-2001-17554.","DOI":"10.1055\/s-2001-17554"},{"key":"5548_CR47","doi-asserted-by":"publisher","unstructured":"Chen Y, Zeng Z, Shen X, Wu Z, Dong Y, Cheng JC. MicroRNA-146a-5p negatively regulates pro-inflammatory cytokine secretion and cell activation in lipopolysaccharide stimulated human hepatic stellate cells through inhibition of toll-like receptor 4 signaling pathways. Int J Mol Sci. 2016;17:1076. https:\/\/doi.org\/10.3390\/ijms17071076.","DOI":"10.3390\/ijms17071076"},{"key":"5548_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112361","volume":"248","author":"N Hu","year":"2020","unstructured":"Hu N, Wang C, Dai X, Zhou M, Gong L, Yu L, et al. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4\/MyD88\/NF-\u03baB signaling pathway. J Ethnopharmacol. 2020;248:112361.","journal-title":"J Ethnopharmacol"},{"key":"5548_CR49","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/intimm\/dxq030","volume":"22","author":"T Kishimoto","year":"2010","unstructured":"Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol. 2010;22:347\u201352.","journal-title":"Int Immunol"},{"key":"5548_CR50","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.21427","volume":"44","author":"N Nieto","year":"2006","unstructured":"Nieto N. Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent kupffer cells on stellate cells. Hepatology. 2006;44:1487\u2013501.","journal-title":"Hepatology"},{"key":"5548_CR51","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","volume":"67","author":"D Xiang","year":"2018","unstructured":"Xiang D, Sun W, Ning B, Zhou T, Li X, Zhong W, et al. The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut. 2018;67:1704.","journal-title":"Gut"},{"key":"5548_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004806","volume":"10","author":"W Li","year":"2016","unstructured":"Li W, Dong H, Huang Y, Chen T, Kong X, Sun H, et al. Clonorchis sinensis co-infection could affect the disease state and treatment response of HBV patients. PLoS Negl Trop Dis. 2016;10:e4806.","journal-title":"PLoS Negl Trop Dis"},{"key":"5548_CR53","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.7150\/jca.30493","volume":"10","author":"X Hu","year":"2019","unstructured":"Hu X, Jiang J, Ni C, Xu Q, Ye S, Wu J, et al. HBV integration-mediated cell apoptosis in HepG2 2 15. J Cancer. 2019;10:4142\u201350.","journal-title":"J Cancer."},{"key":"5548_CR54","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa051285","volume":"354","author":"T Chang","year":"2006","unstructured":"Chang T, Gish RG, de Man R, Gadano A, Sollano J, Chao Y, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. New Engl J Med. 2006;354:1001\u201310.","journal-title":"New Engl J Med"},{"key":"5548_CR55","doi-asserted-by":"publisher","unstructured":"Lapinski TW, Pazgan-Simon M, Plesniak R, Sobala-Szczygiel B. Loss of HBsAg in patients with high levels of HBV DNA during treatment with nucleoside or nucleotide analogs. Hepatitis Monthly. 2020;20(10). https:\/\/doi.org\/10.5812\/hepatmon.106951.","DOI":"10.5812\/hepatmon.106951"},{"key":"5548_CR56","doi-asserted-by":"publisher","unstructured":"Chen P, Xie Q, Lu X, Yu C, Xu K, Ruan B, et al. Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: a community-based study. Medicine (Baltimore). 2017;96:e7766. https:\/\/doi.org\/10.1097\/MD.0000000000007766.","DOI":"10.1097\/MD.0000000000007766"},{"key":"5548_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3748\/wjg.v9.i1.108","volume":"9","author":"D Du","year":"2003","unstructured":"Du D, Jia Z, Li G, Zhou Y. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection. World J Gastroenterol. 2003;9:108.","journal-title":"World J Gastroenterol"},{"key":"5548_CR58","first-page":"1254","volume":"12","author":"A Wang","year":"2015","unstructured":"Wang A, Guan S, Yang K, Zhang H, Sun B, Pan Y, et al. Study of IFN-inducible double-stranded RNA dependent protein kinase on antiviral activity of HBV in vitro. Chinese Pharmacol Bull. 2015;12:1254\u20138.","journal-title":"Chinese Pharmacol Bull"},{"key":"5548_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/00034983.1981.11687405","volume":"75","author":"H Rim","year":"1981","unstructured":"Rim H, Lyu K, Lee J, Joo K. Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) against Clonorchis sinensis infection in man. Ann Trop Med Parasitol. 1981;75:27\u201333.","journal-title":"Ann Trop Med Parasitol"},{"key":"5548_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-4017(00)00258-2","volume":"91","author":"L Veerakumari","year":"2000","unstructured":"Veerakumari L, Munuswamy N. In vitro effect of some anthelmintics on lactate dehydrogenase activity of cotylophoron cotylophorum (Digenea: paramphistomidae). Vet Parasitol. 2000;91:129\u201340.","journal-title":"Vet Parasitol"},{"key":"5548_CR61","first-page":"553","volume":"26","author":"C Zu-yun","year":"2010","unstructured":"Zu-yun C, Jia-lin D, Jiang H. Effect of praziquantel, albendazole and mebendazole on recombinant lactate dehydrogenase of Taenia asiatica. Chinese J Public Health. 2010;26:553\u20134.","journal-title":"Chinese J Public Health"},{"key":"5548_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj5832","volume":"13","author":"S Park","year":"2021","unstructured":"Park S, Friedrich L, Yahya NA, Rohr CM, Chulkov EG, Maillard D, et al. Mechanism of praziquantel action at a parasitic flatworm ion channel. Sci Transl Med. 2021;13:j5832.","journal-title":"Sci Transl Med"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-022-05548-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T22:07:43Z","timestamp":1671228463000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-022-05548-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5548"],"URL":"https:\/\/doi.org\/10.1186\/s13071-022-05548-5","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Clinical Research Ethics Committee of the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (permission number 0204501), and informed consent forms were signed by all participants according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"460"}}